SINT
HEALTHCARESINTX Technologies Inc
$2.40-0.02 (-0.83%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving SINT Today?
No stock-specific AI insight has been generated for SINT yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$1.99$6.78
$2.40
Fundamentals
Market Cap$10M
P/E Ratio—
EPS$-6.16
Dividend Yield—
Dividend / Share—
ROE-3.0%
Profit Margin—
Debt / Equity—
Trading
Volume242K
Avg Volume (10D)—
Shares Outstanding4.1M
SINT News
20 articles- SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial ExecutionYahoo Finance·Mar 23, 2026
- SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle ImplantYahoo Finance·Mar 19, 2026
- SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial PlatformsYahoo Finance·Feb 18, 2026
- SINTX Technologies to Participate in Noble Capital Markets’ Emerging Growth Virtual Equity Conference on February 4–5Yahoo Finance·Jan 29, 2026
- SINTX Technologies to Participate in Sidoti & Company Investor ConferenceYahoo Finance·Dec 8, 2025
- SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific ImplantsYahoo Finance·Dec 1, 2025
- SINTX Reports Pivotal Third Quarter Business Update and Financial Highlights Driven by FDA Clearance, Product and IP Portfolio Expansions and Increased Operational EfficienciesYahoo Finance·Nov 13, 2025
- Envoy Medical, Inc. (COCH) Reports Q3 Loss, Misses Revenue EstimatesYahoo Finance·Nov 10, 2025
- Tandem Diabetes Care, Inc. (TNDM) Reports Q3 Loss, Tops Revenue EstimatesYahoo Finance·Nov 6, 2025
- Neuronetics (STIM) Reports Q3 Loss, Misses Revenue EstimatesYahoo Finance·Nov 4, 2025
- SINTX Technologies Announces Launch of OsseoSculpt™ an Advanced Biologic for Use with SINAPTIC® Foot & Ankle Osteotomy Wedge SystemYahoo Finance·Nov 3, 2025
- SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant SystemYahoo Finance·Oct 20, 2025
- What Makes SINTX TECHNOLOGIES, INC. (SINT) a Strong Momentum Stock: Buy Now?Yahoo Finance·Oct 16, 2025
- UPDATE: SINTX Strengthens Infection-Prevention Portfolio with Newly Allowed U.S. Patent Covering $30 Billion Antipathogenic Addressable MarketYahoo Finance·Oct 16, 2025
- SINTX Technologies Strengthens IP Portfolio with New U.S. Patent Notice of Allowance Covering Antipathogenic FabricsYahoo Finance·Oct 14, 2025
- Several Insiders Invested In Sintx Technologies Flagging Positive NewsYahoo Finance·Sep 18, 2025
- SINTX Technologies to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 9, 2025Yahoo Finance·Sep 9, 2025
- SINTX Technologies Announces Successful Exercise of Warrants for $3.8 Million Gross ProceedsYahoo Finance·Sep 8, 2025
- SINTX Technologies Receives USPTO Notice of Allowance for Silicon Nitride Antipathogenic Platform PatentYahoo Finance·Sep 8, 2025
- Top Midday GainersYahoo Finance·Sep 5, 2025
All 20 articles loaded
Price Data
Open$2.11
Previous Close$2.42
Day High$2.52
Day Low$2.08
52 Week High$6.78
52 Week Low$1.99
52-Week Range
$1.99$6.78
$2.40
Fundamentals
Market Cap$10M
P/E Ratio—
EPS$-6.16
Dividend Yield—
Dividend / Share—
ROE-3.0%
Profit Margin—
Debt / Equity—
Trading
Volume242K
Avg Volume (10D)—
Shares Outstanding4.1M
About SINTX Technologies Inc
Sintx Technologies, Inc., an advanced materials company, researches, develops, manufactures, and markets silicon nitride ceramics in the United States, Europe, and South America. The company is headquartered in Salt Lake City, Utah.
HEALTHCAREMEDICAL DEVICES
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICMEDICAL DEVICES
CIK—
Composite FIGI—
Share Class FIGI—